Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
Ioakeim Sapantzoglou, Obstetrician- Subspecialty in Fetal Medicine at Alexandra Hospital, shared a post on LinkedIn:
“I’m pleased to share our recent systematic review and meta-analysis published in Prenatal Diagnosis, evaluating the incremental diagnostic yield of chromosomal microarray analysis (CMA) over conventional karyotyping in fetuses with fetal growth restriction (FGR).
What we did:
We analyzed 22 observational studies including 2,275 pregnancies with FGR, following PRISMA guidelines, and compared how often CMA detects clinically significant genetic abnormalities that are missed by standard karyotyping.
Key findings:
Isolated FGR: CMA provides an additional 3% diagnostic yield beyond karyotype
FGR with soft markers or non-structural findings: 4% incremental yield
FGR with structural anomalies (malformed FGR): 10% incremental yield
Why this matters:
These results support the role of CMA in refining prenatal diagnosis and improving genetic counseling and risk stratification, even in cases of apparently isolated FGR. The diagnostic benefit is substantially higher when FGR is accompanied by structural abnormalities, but remains clinically relevant even without additional findings.
Clinical implication:
CMA should be strongly considered in the prenatal evaluation of FGR to support individualized counseling, informed decision-making, and optimized perinatal management.
Grateful to all co-authors for this collaboration and to the teams whose data contributed to this analysis.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2
-
Apr 30, 2026, 11:02Platelets Reduce Oxidative Stress Damage in Human Endometrial Stromal Cells in Vitro – RBMO
-
Apr 30, 2026, 10:57GREEG Day 2026: Elevate Your Ultrasound Expertise – GREEG
-
Apr 30, 2026, 10:49Up to Two-Thirds of Elite Female Athletes Experience Irregular Periods – Fertility Plus
-
Apr 30, 2026, 10:47Applications for the ESHRE5 Young Ambassadors 2026 are Still OPEN, But Not for Long! – ESHRE
-
Apr 30, 2026, 10:42The Link Between Lifestyle and Anti-Müllerian Hormone – RBMO